Lung cancer is the commonest cause of cancer death in the western world with current therapeutic interventions having little impact on the epidemic proportions of the disease. As mortality is related to the stage at diagnosis and subsequent treatment, screening for and treating early lung cancer is intuitively appealing. Initial trials however showed chest radiography and sputum cytology were not sensitive enough to use. Initial screening using conventional CT has shown promising results but trials involving multi-slice CT are still underway. At present the question of whether to adopt widespread screening remains to be answered in large randomised trials, in particular the National Lung Screening Trial, results of which are imminently pending.
CITATION STYLE
Byrne, A., & Logan, P. M. (2006). Screening for lung cancer. CPD Journal Radiology Update, 5(2), 85–91. https://doi.org/10.7326/0003-4819-141-8-200410190-00023
Mendeley helps you to discover research relevant for your work.